Results: 16
#1
au:Gonçalves, Fabio Augusto Rodrigues
Filters
Order by
Page
of 2
Next
1.
Diretriz de Tomografia Computadorizada e Ressonância Magnética Cardiovascular da Sociedade Brasileira de Cardiologia e do Colégio Brasileiro de Radiologia – 2024 202 20 2
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Magalhães, Tiago Augusto
; Carneiro, Adriano Camargo de Castro
; Moreira, Valéria de Melo
; Trad, Henrique Simão
; Lopes, Marly Maria Uellendahl
; Cerci, Rodrigo Julio
; Nacif, Marcelo Souto
; Schvartzman, Paulo R.
; Chagas, Antônio Carlos Palandrini
; Costa, Isabela Bispo Santos da Silva
; Schmidt, André
; Shiozaki, Afonso Akio
; Montenegro, Sérgio Tavares
; Piegas, Leopoldo Soares
; Zapparoli, Marcelo
; Nicolau, José Carlos
; Fernandes, Fabio
; Hadlich, Marcelo Souza
; Ghorayeb, Nabil
; Mesquita, Evandro Tinoco
; Gonçalves, Luiz Flávio Galvão
; Ramires, Felix José Alvarez
; Fernandes, Juliano de Lara
; Schwartzmann, Pedro Vellosa
; Rassi, Salvador
; Torreão, Jorge Andion
; Mateos, José Carlos Pachón
; Beck-da-Silva, Luiz
; Silva, Marly Conceição
; Liberato, Gabriela
; Oliveira, Gláucia Maria Moraes de
; Feitosa Filho, Gilson Soares
; Carvalho, Hilka dos Santos Moraes de
; Markman Filho, Brivaldo
; Rocha, Ricardo Paulo de Sousa
; Azevedo Filho, Clerio Francisco de
; Taratsoutchi, Flávio
; Coelho-Filho, Otavio Rizzi
; Kalil Filho, Roberto
; Hajjar, Ludhmila Abrahão
; Ishikawa, Walther Yoshiharu
; Melo, Cíntia Acosta
; Jatene, Ieda Biscegli
; Albuquerque, Andrei Skromov de
; Rimkus, Carolina de Medeiros
; Silva, Paulo Savoia Dias da
; Vieira, Thiago Dieb Ristum
; Jatene, Fabio Biscegli
; Azevedo, Guilherme Sant Anna Antunes de
; Santos, Raul D.
; Monte, Guilherme Urpia
; Ramires, José Antonio Franchini
; Bittencourt, Marcio Sommer
; Avezum, Alvaro
; Silva, Leonardo Sara da
; Abizaid, Alexandre
; Gottlieb, Ilan
; Precoma, Dalton Bertolim
; Szarf, Gilberto
; Sousa, Antônio Carlos Sobral
; Pinto, Ibraim Masciarelli Francisco
; Medeiros, Fábio de Morais
; Caramelli, Bruno
; Parga Filho, José Rodrigues
; Santos, Tiago Senra Garcia dos
; Prazeres, Carlos Eduardo Elias dos
; Lopes, Marcelo Antonio Cartaxo Queiroga
; Avila, Luiz Francisco Rodrigues de
; Scanavacca, Mauricio Ibrahim
; Gowdak, Luis Henrique Wolff
; Barberato, Silvio Henrique
; Nomura, Cesar Higa
; Rochitte, Carlos Eduardo
.
2.
Immunothrombosis and COVID-19 ‒ a nested post-hoc analysis from a 3186 patient cohort in a Latin American public reference hospital COVID19 COVID 19 COVID-1 posthoc post hoc 318 COVID1 1 COVID- 31 3
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Lima, Clarice Antunes de
; Gonçalves, Fabio Augusto Rodrigues
; Besen, Bruno Adler Maccagnan Pinheiro
; Pereira, Antônio José Rodrigues
; Perazzio, Sandro Félix
; Trindade, Evelinda Marramon
; Fonseca, Luiz Augusto Marcondes
; Sumita, Nairo Massakazu
; Pinto, Vanusa Barbosa
; Duarte, Alberto José da Silva
; Manin, Carolina Broco
; Lichtenstein, Arnaldo
.
Abstract Objective COVID-19 is associated with an elevated risk of thromboembolism and excess mortality. Difficulties with best anticoagulation practices and their implementation motivated the current analysis of COVID-19 patients who developed Venous Thromboembolism (VTE). Method This is a post-hoc analysis of a COVID-19 cohort, described in an economic study already published. The authors analyzed a subset of patients with confirmed VTE. We described the characteristics of the cohort, such as demographics, clinical status, and laboratory results. We tested differences amid two subgroups of patients, those with VTE or not, with the competitive risk Fine and Gray model. Results Out of 3186 adult patients with COVID-19, 245 (7.7%) were diagnosed with VTE, 174 (5.4%) of them during admission to the hospital. Four (2.3% of these 174) did not receive prophylactic anticoagulation and 19 (11%) discontinued anticoagulation for at least 3 days, resulting in 170 analyzed. During the first week of hospitalization, the laboratory most altered results were C-reactive protein and D-dimer. Patients with VTE were more critical, had a higher mortality rate, worse SOFA score, and, on average, 50% longer hospital stay. Conclusion Proven VTE incidence in this severe COVID-19 cohort was 7.7%, despite 87% of them complying completely with VTE prophylaxis. The clinician must be aware of the diagnosis of VTE in COVID-19, even in patients receiving proper prophylaxis. COVID19 COVID COVID-1 . (VTE) posthoc post hoc published demographics status model 318 COVID19, 19, 24 7.7% 77 7 (7.7% 17 5.4% 54 5 4 (5.4% 2.3% 23 2 (2.3 1 11% 11 (11% days hospitalization Creactive C reactive Ddimer. Ddimer D dimer. dimer D-dimer critical rate score average 50 stay 87 prophylaxis COVID1 COVID- (VTE 31 7.7 (7.7 5.4 (5.4 2.3 (2. (11 8 7. (7. 5. (5. 2. (2 (1 (7 (5 (
3.
A indústria farmacêutica interfere na sustentabilidade do sistema de saúde pública no Brasil? Uma reflexão sobre a pressão por incorporação de medicamentos
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Tamachiro, Susanna Tawata
; Gonçalves, Fabio Augusto Rodrigues
; Simone, Adriane Lopes Medeiros
; Aguiar, Patricia Melo
.
O objetivo foi analisar a contribuição da indústria farmacêutica na sustentabilidade do Sistema Único de Saúde (SUS), a partir da pressão pela incorporação de medicamentos. Para tanto, foi realizado estudo descritivo das solicitações de incorporação de medicamentos enviadas à Comissão Nacional de Incorporação de Tecnologias no SUS (CONITEC) entre 2012 e 2020. Foram analisadas características como a indicação da tecnologia, avaliação econômica, componente de financiamento, consulta pública e decisão da CONITEC. Os resultados foram comparados segundo o tipo de demandante por teste estatístico. Foram analisadas 514 solicitações, sendo 438 referentes à incorporação. A indústria farmacêutica foi responsável por 37% das solicitações e 33,5% das incorporações. Foram observadas diferenças entre os demandantes quanto ao tipo de avaliação econômica e ao valor de razão custo-utilidade incremental, com metade das demandas da indústria acima do limiar de 3 PIB per capita/QALY. A indústria farmacêutica obteve mais contribuições nas consultas públicas de suas solicitações e apresentou concentração das solicitações em agentes antineoplásicos e imunomoduladores e em anti-infecciosos, sobretudo, para hepatite C e HIV. Também notou-se menor quantidade de demandas da indústria farmacêutica nos Componentes Básico e Estratégico da Assistência Farmacêutica. Os achados apontam o tensionamento entre a expressiva participação da indústria como solicitante, alta mobilização em consultas públicas e ênfase em medicamentos do Componente Especializado e a resistência da CONITEC a essa pressão, com tendência de maior recusa e maior participação de outros solicitantes nos pedidos de ampliação de uso, exclusão e incorporação de medicamentos menos requisitados pela indústria farmacêutica.
The objective is to analyze the contribution of the pharmaceutical industry to the sustainability of the Brazilian Unified National Health System (SUS), based on the pressure for the incorporation of medicines. For this purpose, a descriptive study was conducted on requests for the incorporation of medicines sent to Commission for Incorporation of Technologies in the SUS (CONITEC) from 2012 to 2020. Characteristics such as technology indication, economic evaluation, financing component, public consultation, and CONITEC decision were analyzed. The results were compared according to the type of solicitor using statistical tests. 514 requests were analyzed, of which 438 related to incorporation. The pharmaceutical industry accounted for 37% of the requests and 33.5% of the incorporations. Differences were observed between the solicitors regarding the type of economic evaluation and incremental cost-utility ratio value, with half of the industry’s demands above the threshold of 3 PIB per capita/QALY. The pharmaceutical industry obtained more contributions in public consultations of its requests and presented concentration of requests for antineoplastic and immunomodulatory agents and for anti-infectious, especially for hepatitis C and HIV. There was also a lower number of demands from the pharmaceutical industry in the Basic and Strategic Components of Pharmaceutical Assistance. Our findings point to the tension between the significant participation of the industry as an applicant, the high mobilization of public consultations, the emphasis on Specialized Component drugs, and CONITEC’s resistance to this pressure, with a tendency of greater refusal and greater participation of other solicitors in requests for expansion of use, exclusion, and incorporation of drugs that are less requested by the pharmaceutical industry.
El objetivo fue analizar la contribución de la industria farmacéutica a la sostenibilidad del Sistema Único de Salud (SUS), con base en la presión por la incorporación de medicamentos. Para ello, se realizó un estudio descriptivo de las solicitudes de incorporación de medicamentos enviadas a Comisión de Incorporación de Tecnologías en el SUS (CONITEC) entre el 2012 y el 2020. Se analizaron características como la indicación de tecnología, evaluación económica, componente de financiación, consulta pública y decisión de la CONITEC. Los resultados se compararon según el tipo de demandante por prueba estadística. Se analizaron 514 solicitudes, de las cuales 438 se refieren a la incorporación. La industria farmacéutica fue responsable del 37% de las solicitudes y del 33,5% de las incorporaciones. Se observaron diferencias entre los demandantes en cuanto al tipo de evaluación económica y al valor de la relación costo-utilidad incremental, con la mitad de las demandas de la industria por encima del umbral de 3 PIB per cápita/QALY. La industria farmacéutica obtuvo más contribuciones en las consultas públicas de sus solicitudes y presentó una concentración de solicitudes en agentes antineoplásicos e inmunomoduladores y en antiinfecciosos, especialmente para hepatitis C y VIH. También se constató una menor cantidad de demandas de la industria farmacéutica en los Componentes Básicos y Estratégicos de la Asistencia Farmacéutica. Los hallazgos apuntan a la tensión entre la expresiva participación de la industria como solicitante, alta movilización en las consultas públicas y énfasis en los medicamentos del Componente Especializado y la resistencia de CONITEC a esta presión, con una tendencia de mayor negativa y mayor participación de otros solicitantes en las solicitudes de ampliación del uso, exclusión e incorporación de medicamentos menos requeridos por la industria farmacéutica.
4.
A indústria farmacêutica interfere na sustentabilidade do sistema de saúde pública no Brasil? Uma reflexão sobre a pressão por incorporação de medicamentos
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Tamachiro, Susanna Tawata
; Gonçalves, Fabio Augusto Rodrigues
; Simone, Adriane Lopes Medeiros
; Aguiar, Patricia Melo
.
O objetivo foi analisar a contribuição da indústria farmacêutica na sustentabilidade do Sistema Único de Saúde (SUS), a partir da pressão pela incorporação de medicamentos. Para tanto, foi realizado estudo descritivo das solicitações de incorporação de medicamentos enviadas à Comissão Nacional de Incorporação de Tecnologias no SUS (CONITEC) entre 2012 e 2020. Foram analisadas características como a indicação da tecnologia, avaliação econômica, componente de financiamento, consulta pública e decisão da CONITEC. Os resultados foram comparados segundo o tipo de demandante por teste estatístico. Foram analisadas 514 solicitações, sendo 438 referentes à incorporação. A indústria farmacêutica foi responsável por 37% das solicitações e 33,5% das incorporações. Foram observadas diferenças entre os demandantes quanto ao tipo de avaliação econômica e ao valor de razão custo-utilidade incremental, com metade das demandas da indústria acima do limiar de 3 PIB per capita/QALY. A indústria farmacêutica obteve mais contribuições nas consultas públicas de suas solicitações e apresentou concentração das solicitações em agentes antineoplásicos e imunomoduladores e em anti-infecciosos, sobretudo, para hepatite C e HIV. Também notou-se menor quantidade de demandas da indústria farmacêutica nos Componentes Básico e Estratégico da Assistência Farmacêutica. Os achados apontam o tensionamento entre a expressiva participação da indústria como solicitante, alta mobilização em consultas públicas e ênfase em medicamentos do Componente Especializado e a resistência da CONITEC a essa pressão, com tendência de maior recusa e maior participação de outros solicitantes nos pedidos de ampliação de uso, exclusão e incorporação de medicamentos menos requisitados pela indústria farmacêutica.
The objective is to analyze the contribution of the pharmaceutical industry to the sustainability of the Brazilian Unified National Health System (SUS), based on the pressure for the incorporation of medicines. For this purpose, a descriptive study was conducted on requests for the incorporation of medicines sent to Commission for Incorporation of Technologies in the SUS (CONITEC) from 2012 to 2020. Characteristics such as technology indication, economic evaluation, financing component, public consultation, and CONITEC decision were analyzed. The results were compared according to the type of solicitor using statistical tests. 514 requests were analyzed, of which 438 related to incorporation. The pharmaceutical industry accounted for 37% of the requests and 33.5% of the incorporations. Differences were observed between the solicitors regarding the type of economic evaluation and incremental cost-utility ratio value, with half of the industry’s demands above the threshold of 3 PIB per capita/QALY. The pharmaceutical industry obtained more contributions in public consultations of its requests and presented concentration of requests for antineoplastic and immunomodulatory agents and for anti-infectious, especially for hepatitis C and HIV. There was also a lower number of demands from the pharmaceutical industry in the Basic and Strategic Components of Pharmaceutical Assistance. Our findings point to the tension between the significant participation of the industry as an applicant, the high mobilization of public consultations, the emphasis on Specialized Component drugs, and CONITEC’s resistance to this pressure, with a tendency of greater refusal and greater participation of other solicitors in requests for expansion of use, exclusion, and incorporation of drugs that are less requested by the pharmaceutical industry.
El objetivo fue analizar la contribución de la industria farmacéutica a la sostenibilidad del Sistema Único de Salud (SUS), con base en la presión por la incorporación de medicamentos. Para ello, se realizó un estudio descriptivo de las solicitudes de incorporación de medicamentos enviadas a Comisión de Incorporación de Tecnologías en el SUS (CONITEC) entre el 2012 y el 2020. Se analizaron características como la indicación de tecnología, evaluación económica, componente de financiación, consulta pública y decisión de la CONITEC. Los resultados se compararon según el tipo de demandante por prueba estadística. Se analizaron 514 solicitudes, de las cuales 438 se refieren a la incorporación. La industria farmacéutica fue responsable del 37% de las solicitudes y del 33,5% de las incorporaciones. Se observaron diferencias entre los demandantes en cuanto al tipo de evaluación económica y al valor de la relación costo-utilidad incremental, con la mitad de las demandas de la industria por encima del umbral de 3 PIB per cápita/QALY. La industria farmacéutica obtuvo más contribuciones en las consultas públicas de sus solicitudes y presentó una concentración de solicitudes en agentes antineoplásicos e inmunomoduladores y en antiinfecciosos, especialmente para hepatitis C y VIH. También se constató una menor cantidad de demandas de la industria farmacéutica en los Componentes Básicos y Estratégicos de la Asistencia Farmacéutica. Los hallazgos apuntan a la tensión entre la expresiva participación de la industria como solicitante, alta movilización en las consultas públicas y énfasis en los medicamentos del Componente Especializado y la resistencia de CONITEC a esta presión, con una tendencia de mayor negativa y mayor participación de otros solicitantes en las solicitudes de ampliación del uso, exclusión e incorporación de medicamentos menos requeridos por la industria farmacéutica.
5.
Práticas de ressuscitação volêmica em unidades de terapia intensiva brasileiras: uma análise secundária do estudo Fluid-TRIPS
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Freitas, Flavio Geraldo Rezende de
; Hammond, Naomi
; Li, Yang
; Azevedo, Luciano Cesar Pontes de
; Cavalcanti, Alexandre Biasi
; Taniguchi, Leandro
; Gobatto, André
; Japiassú, André Miguel
; Bafi, Antonio Tonete
; Mazza, Bruno Franco
; Noritomi, Danilo Teixeira
; Dal-Pizzol, Felipe
; Bozza, Fernando
; Salluh, Jorge Ibrahin Figueira
; Westphal, Glauco Adrieno
; Soares, Márcio
; Assunção, Murillo Santucci César de
; Lisboa, Thiago
; Lobo, Suzana Margarete Ajeje
; Barbosa, Achilles Rohlfs
; Ventura, Adriana Fonseca
; Souza, Ailson Faria de
; Silva, Alexandre Francisco
; Toledo, Alexandre
; Reis, Aline
; Cembranel, Allan
; Rea Neto, Alvaro
; Gut, Ana Lúcia
; Justo, Ana Patricia Pierre
; Santos, Ana Paula
; Albuquerque, André Campos D. de
; Scazufka, André
; Rodrigues, Antonio Babo
; Fernandino, Bruno Bonaccorsi
; Silva, Bruno Goncalves
; Vidal, Bruno Sarno
; Pinheiro, Bruno Valle
; Pinto, Bruno Vilela Costa
; Feijo, Carlos Augusto Ramos
; Abreu Filho, Carlos de
; Bosso, Carlos Eduardo da Costa Nunes
; Moreira, Carlos Eduardo Nassif
; Ramos, Carlos Henrique Ferreira
; Tavares, Carmen
; Arantes, Cidamaiá
; Grion, Cintia
; Mendes, Ciro Leite
; Kmohan, Claudio
; Piras, Claudio
; Castro, Cristine Pilati Pileggi
; Lins, Cyntia
; Beraldo, Daniel
; Fontes, Daniel
; Boni, Daniela
; Castiglioni, Débora
; Paisani, Denise de Moraes
; Pedroso, Durval Ferreira Fonseca
; Mattos, Ederson Roberto
; Brito Sobrinho, Edgar de
; Troncoso, Edgar M. V.
; Rodrigues Filho, Edison Moraes
; Nogueira, Eduardo Enrico Ferrari
; Ferreira, Eduardo Leme
; Pacheco, Eduardo Souza
; Jodar, Euzebio
; Ferreira, Evandro L. A.
; Araujo, Fabiana Fernandes de
; Trevisol, Fabiana Schuelter
; Amorim, Fábio Ferreira
; Giannini, Fabio Poianas
; Santos, Fabrício Primitivo Matos
; Buarque, Fátima
; Lima, Felipe Gallego
; Costa, Fernando Antonio Alvares da
; Sad, Fernando Cesar dos Anjos
; Aranha, Fernando G.
; Ganem, Fernando
; Callil, Flavio
; Costa Filho, Francisco Flávio
; Dall´Arto, Frederico Toledo Campo
; Moreno, Geovani
; Friedman, Gilberto
; Moralez, Giulliana Martines
; Silva, Guilherme Abdalla da
; Costa, Guilherme
; Cavalcanti, Guilherme Silva
; Cavalcanti, Guilherme Silva
; Betônico, Gustavo Navarro
; Betônico, Gustavo Navarro
; Reis, Hélder
; Araujo, Helia Beatriz N.
; Hortiz Júnior, Helio Anjos
; Guimaraes, Helio Penna
; Urbano, Hugo
; Maia, Israel
; Santiago Filho, Ivan Lopes
; Farhat Júnior, Jamil
; Alvarez, Janu Rangel
; Passos, Joel Tavares
; Paranhos, Jorge Eduardo da Rocha
; Marques, José Aurelio
; Moreira Filho, José Gonçalves
; Andrade, Jose Neto
; Sobrinho, José Onofre de C
; Bezerra, Jose Terceiro de Paiva
; Alves, Juliana Apolônio
; Ferreira, Juliana
; Gomes, Jussara
; Sato, Karina Midori
; Gerent, Karine
; Teixeira, Kathia Margarida Costa
; Conde, Katia Aparecida Pessoa
; Martins, Laércia Ferreira
; Figueirêdo, Lanese
; Rezegue, Leila
; Tcherniacovsk, Leonardo
; Ferraz, Leone Oliveira
; Cavalcante, Liane
; Rabelo, Ligia
; Miilher, Lilian
; Garcia, Lisiane
; Tannous, Luana
; Hajjar, Ludhmila Abrahão
; Paciência, Luís Eduardo Miranda
; Cruz Neto, Luiz Monteiro da
; Bley, Macia Valeria
; Sousa, Marcelo Ferreira
; Puga, Marcelo Lourencini
; Romano, Marcelo Luz Pereira
; Nobrega, Marciano
; Arbex, Marcio
; Rodrigues, Márcio Leite
; Guerreiro, Márcio Osório
; Rocha, Marcone
; Alves, Maria Angela Pangoni
; Alves, Maria Angela Pangoni
; Rosa, Maria Doroti
; Dias, Mariza D’Agostino
; Martins, Miquéias
; Oliveira, Mirella de
; Moretti, Miriane Melo Silveira
; Matsui, Mirna
; Messender, Octavio
; Santarém, Orlando Luís de Andrade
; Silveira, Patricio Júnior Henrique da
; Vassallo, Paula Frizera
; Antoniazzi, Paulo
; Gottardo, Paulo César
; Correia, Paulo
; Ferreira, Paulo
; Torres, Paulo
; Silva, Pedro Gabrile M. de Barros e
; Foernges, Rafael
; Gomes, Rafael
; Moraes, Rafael
; Nonato filho, Raimundo
; Borba, Renato Luis
; Gomes, Renato V
; Cordioli, Ricardo
; Lima, Ricardo
; López, Ricardo Pérez
; Gargioni, Ricardo Rath de Oliveira
; Rosenblat, Richard
; Souza, Roberta Machado de
; Almeida, Roberto
; Narciso, Roberto Camargo
; Marco, Roberto
; waltrick, Roberto
; Biondi, Rodrigo
; Figueiredo, Rodrigo
; Dutra, Rodrigo Santana
; Batista, Roseane
; Felipe, Rouge
; Franco, Rubens Sergio da Silva
; Houly, Sandra
; Faria, Sara Socorro
; Pinto, Sergio Felix
; Luzzi, Sergio
; Sant’ana, Sergio
; Fernandes, Sergio Sonego
; Yamada, Sérgio
; Zajac, Sérgio
; Vaz, Sidiner Mesquita
; Bezerra, Silvia Aparecida Bezerra
; Farhat, Tatiana Bueno Tardivo
; Santos, Thiago Martins
; Smith, Tiago
; Silva, Ulysses V. A.
; Damasceno, Valnei Bento
; Nobre, Vandack
; Dantas, Vicente Cés de Souza
; Irineu, Vivian Menezes
; Bogado, Viviane
; Nedel, Wagner
; Campos Filho, Walther
; Dantas, Weidson
; Viana, William
; Oliveira Filho, Wilson de
; Delgadinho, Wilson Martins
; Finfer, Simon
; Machado, Flavia Ribeiro
.
RESUMO Objetivo: Descrever as práticas de ressuscitação volêmica em unidades de terapia intensiva brasileiras e compará-las com as de outros países participantes do estudo Fluid-TRIPS. Métodos: Este foi um estudo observacional transversal, prospectivo e internacional, de uma amostra de conveniência de unidades de terapia intensiva de 27 países (inclusive o Brasil), com utilização da base de dados Fluid-TRIPS compilada em 2014. Descrevemos os padrões de ressuscitação volêmica utilizados no Brasil em comparação com os de outros países e identificamos os fatores associados com a escolha dos fluidos. Resultados: No dia do estudo, foram incluídos 3.214 pacientes do Brasil e 3.493 pacientes de outros países, dos quais, respectivamente, 16,1% e 26,8% (p < 0,001) receberam fluidos. A principal indicação para ressuscitação volêmica foi comprometimento da perfusão e/ou baixo débito cardíaco (Brasil 71,7% versus outros países 56,4%; p < 0,001). No Brasil, a percentagem de pacientes que receberam soluções cristaloides foi mais elevada (97,7% versus 76,8%; p < 0,001), e solução de cloreto de sódio a 0,9% foi o cristaloide mais comumente utilizado (62,5% versus 27,1%; p < 0,001). A análise multivariada sugeriu que os níveis de albumina se associaram com o uso tanto de cristaloides quanto de coloides, enquanto o tipo de prescritor dos fluidos se associou apenas com o uso de cristaloides. Conclusão: Nossos resultados sugerem que cristaloides são usados mais frequentemente do que coloides para ressuscitação no Brasil, e essa discrepância, em termos de frequências, é mais elevada do que em outros países. A solução de cloreto de sódio 0,9% foi o cristaloide mais frequentemente prescrito. Os níveis de albumina sérica e o tipo de prescritor de fluidos foram os fatores associados com a escolha de cristaloides ou coloides para a prescrição de fluidos.
Abstract Objective: To describe fluid resuscitation practices in Brazilian intensive care units and to compare them with those of other countries participating in the Fluid-TRIPS. Methods: This was a prospective, international, cross-sectional, observational study in a convenience sample of intensive care units in 27 countries (including Brazil) using the Fluid-TRIPS database compiled in 2014. We described the patterns of fluid resuscitation use in Brazil compared with those in other countries and identified the factors associated with fluid choice. Results: On the study day, 3,214 patients in Brazil and 3,493 patients in other countries were included, of whom 16.1% and 26.8% (p < 0.001) received fluids, respectively. The main indication for fluid resuscitation was impaired perfusion and/or low cardiac output (Brazil: 71.7% versus other countries: 56.4%, p < 0.001). In Brazil, the percentage of patients receiving crystalloid solutions was higher (97.7% versus 76.8%, p < 0.001), and 0.9% sodium chloride was the most commonly used crystalloid (62.5% versus 27.1%, p < 0.001). The multivariable analysis suggested that the albumin levels were associated with the use of both crystalloids and colloids, whereas the type of fluid prescriber was associated with crystalloid use only. Conclusion: Our results suggest that crystalloids are more frequently used than colloids for fluid resuscitation in Brazil, and this discrepancy in frequencies is higher than that in other countries. Sodium chloride (0.9%) was the crystalloid most commonly prescribed. Serum albumin levels and the type of fluid prescriber were the factors associated with the choice of crystalloids or colloids for fluid resuscitation.
https://doi.org/10.5935/0103-507x.20210028
273 downloads
6.
COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Miethke-Morais, Anna
; Cassenote, Alex
; Piva, Heloisa
; Tokunaga, Eric
; Cobello, Vilson
; Gonçalves, Fabio Augusto Rodrigues
; Lobo, Renata dos Santos
; Trindade, Evelinda
; D'Albuquerque, Luiz Augusto Carneiro
; Haddad, Luciana
.
ABSTRACT Introduction: Although patients’ clinical conditions have been shown to be associated with coronavirus disease (COVID-19) severity and outcome, their impact on hospital costs are not known. This economic evaluation of COVID-19 admissions aimed to assess direct and fixed hospital costs and describe their particularities in different clinical and demographic conditions and outcomes in the largest public hospital in Latin America, located in São Paulo, Brazil, where a whole institute was exclusively dedicated to COVID-19 patients in response to the pandemic. Methods: This is a partial economic evaluation performed from the hospitaĺs perspective and is a prospective, observational cohort study to assess hospitalization costs of suspected and confirmed COVID-19 patients admitted between March 30 and June 30, 2020, to Hospital das Clínicas of the University of São Paulo Medical School (HCFMUSP) and followed until discharge, death, or external transfer. Microand macro-costing methodologies were used to describe and analyze the total cost associated with each patient’s underlying medical conditions, itinerary and outcomes as well as the cost components of different hospital sectors. Results: The average cost of the 3254 admissions (51.7% of which involved intensive care unit stays) was US$12,637.42. The overhead cost was its main component. Sex, age and underlying hypertension (US$14,746.77), diabetes (US$15,002.12), obesity (US$18,941.55), chronic renal failure (US$15,377.84), and rheumatic (US$17,764.61), hematologic (US $15,908.25) and neurologic (US$15,257.95) diseases were associated with higher costs. Age strata >69 years, reverse transcription polymerase chain reaction (RT-PCR)-confirmed COVID-19, comorbidities, use of mechanical ventilation or dialysis, surgery and outcomes remained associated with higher costs. Conclusion: Knowledge of COVID-19 hospital costs can aid in the development of a comprehensive approach for decision-making and planning for future risk management.
https://doi.org/10.1016/j.bjid.2021.101609
70 downloads
7.
Use and misuse of biomarkers and the role of D-dimer and C-reactive protein in the management of COVID-19: A post-hoc analysis of a prospective cohort study
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Gonçalves, Fabio Augusto Rodrigues
; Besen, Bruno Adler Maccagnan Pinheiro
; Lima, Clarice Antunes de
; Corá, Aline Pivetta
; Pereira, Antônio José Rodrigues
; Perazzio, Sandro Félix
; Gouvea, Christiane Pereira
; Fonseca, Luiz Augusto Marcondes
; Trindade, Evelinda Marramon
; Sumita, Nairo Massakazu
; Duarte, Alberto José da Silva
; Lichtenstein, Arnaldo
; Bonfa, Eloisa
; Utiyama, Edivaldo M.
; Segurado, Aluisio C.
; Perondi, Beatriz
; Miethke-Morais, Anna
; Montal, Amanda C.
; Harima, Leila
; Fusco, Solange R. G.
; Silva, Marjorie F.
; Rocha, Marcelo C.
; Marcilio, Izabel
; Rios, Izabel Cristina
; Kawano, Fabiane Yumi Ogihara
; Jesus, Maria Amélia de
; Kallas, Ésper George
; Carmo, Carolina
; Tanaka, Clarice
; Souza, Heraldo Possolo de
; Marchini, Julio F. M.
; Carvalho, Carlos
; Ferreira, Juliana C.
; Levin, Anna Sara Shafferman
; Oliveira, Maura Salaroli
; Guimarães, Thaís
; Lázari, Carolina dos Santos
; Sabino, Ester
; Magri, Marcello M. C.
; Barros-Filho, Tarcisio E. P.
; Francisco, Maria Cristina Peres Braido
; Costa, Silvia F.
.
OBJECTIVE: Coronavirus disease 2019 (COVID-19) is associated with high mortality among hospitalized patients and incurs high costs. Severe acute respiratory syndrome coronavirus 2 infection can trigger both inflammatory and thrombotic processes, and these complications can lead to a poorer prognosis. This study aimed to evaluate the association and temporal trends of D-dimer and C-reactive protein (CRP) levels with the incidence of venous thromboembolism (VTE), hospital mortality, and costs among inpatients with COVID-19. METHODS: Data were extracted from electronic patient records and laboratory databases. Crude and adjusted associations for age, sex, number of comorbidities, Sequential Organ Failure Assessment score at admission, and D-dimer or CRP logistic regression models were used to evaluate associations. RESULTS: Between March and June 2020, COVID-19 was documented in 3,254 inpatients. The D-dimer level ≥4,000 ng/mL fibrinogen equivalent unit (FEU) mortality odds ratio (OR) was 4.48 (adjusted OR: 1.97). The CRP level ≥220 mg/dL OR for death was 7.73 (adjusted OR: 3.93). The D-dimer level ≥4,000 ng/mL FEU VTE OR was 3.96 (adjusted OR: 3.26). The CRP level ≥220 mg/dL OR for VTE was 2.71 (adjusted OR: 1.92). All these analyses were statistically significant (p<0.001). Stratified hospital costs demonstrated a dose-response pattern. Adjusted D-dimer and CRP levels were associated with higher mortality and doubled hospital costs. In the first week, elevated D-dimer levels predicted VTE occurrence and systemic inflammatory harm, while CRP was a hospital mortality predictor. CONCLUSION: D-dimer and CRP levels were associated with higher hospital mortality and a higher incidence of VTE. D-dimer was more strongly associated with VTE, although its discriminative ability was poor, while CRP was a stronger predictor of hospital mortality. Their use outside the usual indications should not be modified and should be discouraged.
8.
BRAZILIAN GASTRIC CANCER ASSOCIATION GUIDELINES (PART 2): UPDATE ON TREATMENT
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
BARCHI, Leandro Cardoso
; RAMOS, Marcus Fernando Kodama Pertille
; DIAS, André Roncon
; FORONES, Nora Manoukian
; CARVALHO, Marineide Prudêncio de
; CASTRO, Osvaldo Antonio Prado
; KASSAB, Paulo
; COSTA-JÚNIOR, Wilson Luiz da
; WESTON, Antônio Carlos
; ZILBERSTEIN, Bruno
; Ferraz, Álvaro Antônio Bandeira
; ZeideCharruf, Amir
; Brandalise, André
; Silva, André Maciel da
; Alves, Barlon
; Marins, Carlos Augusto Martinez
; Malheiros, Carlos Alberto
; Leite, Celso Vieira
; Bresciani, Claudio José Caldas
; Szor, Daniel
; Mucerino, Donato Roberto
; Wohnrath, Durval R.
; JirjossIlias, Elias
; Martins Filho, Euclides Dias
; PinatelLopasso, Fabio
; Coimbra, Felipe José Fernandez
; Felippe, Fernando E. Cruz
; Tomasisch, Flávio Daniel Saavedra
; Takeda, Flavio Roberto
; Ishak, Geraldo
; Laporte, Gustavo Andreazza
; Silva, Herbeth José Toledo
; Cecconello, Ivan
; Rodrigues, Joaquim José Gama
; Grande, José Carlos Del
; Lourenço, Laércio Gomes
; Motta, Leonardo Milhomem da
; Ferraz, Leonardo Rocha
; Moreira, Luis Fernando
; Lopes, Luis Roberto
; Toneto, Marcelo Garcia
; Mester, Marcelo
; Rodrigues, Marco Antônio Gonçalves
; Franciss, Maurice Youssef
; AdamiAndreollo, Nelson
; Corletta, Oly Campos
; Yagi, Osmar Kenji
; Malafaia, Osvaldo
; Assumpção, Paulo Pimentel
; Savassi-Rocha, Paulo Roberto
; Colleoni Neto, Ramiro
; Oliveira, Rodrigo Jose de
; AissarSallun, Rubens Antonio
; Weschenfelder, Rui
; Oliveira, Saint Clair Vieira de
; Abreu, Thiago Boechat de
; Castria, Tiago Biachi de
; Ribeiro Junior, Ulysses
; Barra, Williams
; Freitas Júnior, Wilson Rodrigues de
.
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Journal Metrics
RESUMO Racional: O II Consenso Brasileiro de Câncer Gástrico da Associação Brasileira de Câncer Gástrico ABCG (Parte 1) foi recentemente publicado. Nesta ocasião inúmeros especialistas que atuam no tratamento desta doença expressaram suas opiniões diante declarações apresentadas. Objetivo: Apresentar as Diretrizes da ABCG (Parte 2) quanto às indicações de tratamento cirúrgico, técnicas operatórias, extensão de ressecção e terapia combinada. Métodos: Para formulação destas diretrizes os autores realizaram extensa e atual revisão referente a cada declaração presente no II Consenso, utilizando as bases Medline/PubMed, Cochrane Library e SciELO, inicialmente com os seguintes descritores: câncer gástrico, gastrectomia, linfadenectomia, terapia combinada. Ainda, cada declaração foi classificada de acordo com o nível de evidência e grau de recomendação. Resultados: Das 43 declarações presentes neste estudo, 11 (25,6%) foram classificadas com nível de evidência A, 20 (46,5%) B e 12 (27,9%) C. Quanto ao grau de recomendação, 18 (41,9%) declarações obtiveram grau de recomendação 1, 14 (32,6%) 2a, 10 (23,3%) 2b e um (2,3%) 3. Conclusão: O complemento das diretrizes aqui presentes possibilita que cirurgiões e oncologistas que atuam no combate ao câncer gástrico possam oferecer o melhor tratamento possível, de acordo com as condições locais disponíveis.
ABSTRACT Background : The II Brazilian Consensus on Gastric Cancer of the Brazilian Gastric Cancer Association BGCA (Part 1) was recently published. On this occasion, countless specialists working in the treatment of this disease expressed their opinion in the face of the statements presented. Aim : To present the BGCA Guidelines (Part 2) regarding indications for surgical treatment, operative techniques, extension of resection and multimodal treatment. Methods: To formulate these guidelines, the authors carried out an extensive and current review regarding each declaration present in the II Consensus, using the Medline/PubMed, Cochrane Library and SciELO databases initially with the following descriptors: gastric cancer, gastrectomy, lymphadenectomy, multimodal treatment. In addition, each statement was classified according to the level of evidence and degree of recommendation. Results : Of the 43 statements present in this study, 11 (25,6%) were classified with level of evidence A, 20 (46,5%) B and 12 (27,9%) C. Regarding the degree of recommendation, 18 (41,9%) statements obtained grade of recommendation 1, 14 (32,6%) 2a, 10 (23,3%) 2b e one (2,3%) 3. Conclusion : The guidelines complement of the guidelines presented here allows surgeons and oncologists who work to combat gastric cancer to offer the best possible treatment, according to the local conditions available.
https://doi.org/10.1590/0102-672020210001e1563
768 downloads
9.
II BRAZILIAN CONSENSUS ON GASTRIC CANCER BY THE BRAZILIAN GASTRIC CANCER ASSOCIATION
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
BARCHI, Leandro Cardoso
; RAMOS, Marcus Fernando Kodama Pertille
; DIAS, André Roncon
; ANDREOLLO, Nelson Adami
; WESTON, Antônio Carlos
; LOURENÇO, Laércio Gomes
; MALHEIROS, Carlos Alberto
; KASSAB, Paulo
; ZILBERSTEIN, Bruno
; Ferraz, Álvaro Antônio Bandeira
; Charruf, Amir Zeide
; Brandalise, André
; Silva, André Maciel da
; Alves, Barlon
; Marins, Carlos Augusto Martinez
; Leite, Celso Vieira
; Bresciani, Claudio José Caldas
; Szor, Daniel
; Mucerino, Donato Roberto
; Wohnrath, Durval R.
; Ilias, Elias Jirjoss
; Martins Filho, Euclides Dias
; Lopasso, Fabio Pinatel
; Coimbra, Felipe José Fernandez
; Felippe, Fernando E. Cruz
; Tomasisch, Flávio Daniel Saavedra
; Takeda, Flavio Roberto
; Ishak, Geraldo
; Laporte, Gustavo Andreazza
; Silva, Herbeth José Toledo
; Cecconello, Ivan
; Rodrigues, Joaquim José Gama
; Grande, José Carlos Del
; Motta, Leonardo Milhomem da
; Ferraz, Leonardo Rocha
; Moreira, Luis Fernando
; Lopes, Luis Roberto
; Toneto, Marcelo Garcia
; Mester, Marcelo
; Rodrigues, Marco Antônio Gonçalves
; Carvalho, Marineide Prudêncio de
; Franciss, Maurice Youssef
; Forones, Nora Manoukian
; Corletta, Oly Campos
; Yagi, Osmar Kenji
; Castro, Osvaldo Antonio Prado
; Malafaia, Osvaldo
; Assumpção, Paulo Pimentel
; Savassi-Rocha, Paulo Roberto
; Colleoni Neto, Ramiro
; Oliveira, Rodrigo Jose de
; Sallun, Rubens Antonio Aissar
; Weschenfelder, Rui
; Oliveira, Saint Clair Vieira de
; Abreu, Thiago Boechat de
; Castria, Tiago Biachi de
; Ribeiro Junior, Ulysses
; Barra, Williams
; Costa Júnior, Wilson Luiz da
; Freitas Júnior, Wilson Rodrigues de
.
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Journal Metrics
RESUMO Racional: Desde a publicação do primeiro Consenso Brasileiro sobre Câncer Gástrico em 2012 realizado pela Associação Brasileira de Câncer Gástrico (ABCG), novos conceitos sobre o diagnóstico, estadiamento, tratamento e seguimento foram incorporados. Objetivo: Promover uma atualização aos profissionais que atuam no combate ao câncer gástrico (CG) e fornecer diretrizes quanto ao manejo dos pacientes portadores desta afecção. Métodos: Cinquenta e nove especialistas responderam 67 declarações sobre o diagnóstico, estadiamento, tratamento e prognóstico do CG com cinco alternativas possíveis: 1) concordo plenamente; 2) concordo parcialmente; 3) indeciso; 4) discordo e 5) discordo fortemente. Foi considerado consenso a concordância de pelo menos 80% da soma das respostas “concordo plenamente” e “concordo parcialmente”. Este artigo apresenta apenas as respostas dos especialistas participantes. Os comentários sobre cada declaração, assim como uma revisão da literatura serão apresentados em publicações futuras. Resultados: Das 67 declarações, houve consenso em 50 (74%). Em 10 declarações, houve concordância de 100%. Conclusão: O tratamento do câncer gástrico evoluiu consideravelmente nos últimos anos. Este consenso reúne princípios consolidados nas últimas décadas, novos conhecimentos adquiridos recentemente, assim como perspectivas promissoras sobre o manejo desta doença.
ABSTRACT Background: Since the publication of the first Brazilian Consensus on Gastric Cancer (GC) in 2012 carried out by the Brazilian Gastric Cancer Association, new concepts on diagnosis, staging, treatment and follow-up have been incorporated. Aim: This new consensus is to promote an update to professionals working in the fight against GC and to provide guidelines for the management of patients with this condition. Methods: Fifty-nine experts answered 67 statements regarding the diagnosis, staging, treatment and prognosis of GC with five possible alternatives: 1) fully agree; 2) partially agree; 3) undecided; 4) disagree and 5) strongly disagree A consensus was adopted when at least 80% of the sum of the answers “fully agree” and “partially agree” was reached. This article presents only the responses of the participating experts. Comments on each statement, as well as a literature review, will be presented in future publications. Results: Of the 67 statements, there was consensus in 50 (74%). In 10 declarations, there was 100% agreement. Conclusion: The gastric cancer treatment has evolved considerably in recent years. This consensus gathers consolidated principles in the last decades, new knowledge acquired recently, as well as promising perspectives on the management of this disease.
https://doi.org/10.1590/0102-672020190001e1514
3675 downloads
10.
BRAZILIAN GASTRIC CANCER ASSOCIATION GUIDELINES (PART 1): AN UPDATE ON DIAGNOSIS, STAGING, ENDOSCOPIC TREATMENT AND FOLLOW-UP
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
BARCHI, Leandro Cardoso
; RAMOS, Marcus Fernando Kodama Pertille
; YAGI, Osmar Kenji
; MUCERINO, Donato Roberto
; BRESCIANI, Claudio José Caldas
; RIBEIRO JÚNIOR, Ulysses
; ANDREOLLO, Nelson Adami
; ASSUMPÇÃO, Paulo Pimentel
; WESTON, Antônio Carlos
; COLLEONI NETO, Ramiro
; ZILBERSTEIN, Bruno
; Ferraz, Álvaro Antônio Bandeira
; Charruf, Amir Zeide
; Dias, André Roncon
; Brandalise, André
; Silva, André Maciel da
; Alves, Barlon
; Malheiros, Carlos Alberto
; Marins, Carlos Augusto Martinez
; Leite, Celso Vieira
; Szor, Daniel
; Wohnrath, Durval R.
; Ilias, Elias Jirjoss
; Martins Filho, Euclides Dias
; Lopasso, Fabio Pinatel
; Coimbra, Felipe José Fernandez
; Felippe, Fernando E. Cruz
; Tomasisch, Flávio Daniel Saavedra
; Takeda, Flavio Roberto
; Ishak, Geraldo
; Laporte, Gustavo Andreazza
; Silva, Herbeth José Toledo
; Cecconello, Ivan
; Rodrigues, Joaquim José Gama
; Grande, José Carlos Del
; Lourenço, Laércio Gomes
; Motta, Leonardo Milhomem da
; Ferraz, Leonardo Rocha
; Moreira, Luis Fernando
; Lopes, Luis Roberto
; Toneto, Marcelo Garcia
; Mester, Marcelo
; Rodrigues, Marco Antônio Gonçalves
; Carvalho, Marineide Prudêncio de
; Franciss, Maurice Youssef
; Forones, Nora Manoukian
; Corletta, Oly Campos
; Castro, Osvaldo Antonio Prado
; Malafaia, Osvaldo
; Kassab, Paulo
; Savassi-Rocha, Paulo Roberto
; Oliveira, Rodrigo Jose de
; Sallun, Rubens Antonio Aissar
; Weschenfelder, Rui
; Oliveira, Saint Clair Vieira de
; Abreu, Thiago Boechat de
; Castria, Tiago Biachi de
; Barra, Williams
; Costa Júnior, Wilson Luiz da
; Freitas Júnior, Wilson Rodrigues de
.
ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Journal Metrics
RESUMO Racional: O II Consenso Brasileiro de Câncer Gástrico da Associação Brasileira de Câncer Gástrico (ABCG) foi recentemente publicado. Nesta ocasião, inúmeros especialistas que atuam no tratamento desta doença expressaram sua opinião diante declarações apresentadas. Objetivo: Apresentar as Diretrizes da ABCG (Parte 1) quanto ao diagnóstico, estadiamento, tratamento endoscópico e seguimento dos pacientes com câncer gástrico. Métodos: Para formulação destas Diretrizes os autores realizaram extensa e atual revisão referente a cada declaração presente no II Consenso, utilizando as bases Medline/PubMed, Cochrane Library e SciELO com os seguintes descritores: câncer gástrico, estadiamento, tratamento endoscópico e seguimento. Ainda, cada declaração foi classificada de acordo com o nível de evidência e grau de recomendação. Resultados: Das 24 declarações, duas (8,3%) foram classificadas com nível de evidência A, 11 (45,8%) B e 11 (45,8%) C. Quanto ao grau de recomendação, seis (25%) declarações obtiveram grau de recomendação 1, nove (37,5%) grau 2a, seis (25%) 2b e três (12,5%) 3. Conclusão: As diretrizes aqui presentes têm a finalidade de auxiliar os profissionais que atuam no combate ao câncer gástrico com informações relevantes e atuais, permitindo que sejam aplicadas na prática médica diária.
ABSTRACT Background: The II Brazilian Consensus on Gastric Cancer by the Brazilian Gastric Cancer Association (ABCG) was recently published. On this occasion, several experts in gastric cancer expressed their opinion before the statements presented. Aim: To present the ABCG Guidelines (part 1) regarding the diagnosis, staging, endoscopic treatment and follow-up of gastric cancer patients. Methods: To forge these Guidelines, the authors carried out an extensive and current review regarding each statement present in the II Consensus, using the Medline/PubMed, Cochrane Library and SciELO databases with the following descriptors: gastric cancer, staging, endoscopic treatment and follow-up. In addition, each statement was classified according to the level of evidence and degree of recommendation. Results: Of the 24 statements, two (8.3%) were classified with level of evidence A, 11 (45.8%) with B and 11 (45.8%) with C. As for the degree of recommendation, six (25%) statements obtained grade of recommendation 1, nine (37.5%) recommendation 2a, six (25%) 2b and three (12.5%) grade 3. Conclusion: The guidelines presented here are intended to assist professionals working in the fight against gastric cancer with relevant and current information, granting them to be applied in the daily medical practice.
https://doi.org/10.1590/0102-672020200003e1535
2100 downloads
11.
Comment on the study Coronary Artery Bypass Surgery in Brazil: Analysis of the National Reality Through the Bypass Registry that was presented at the 46th Congress of the Brazilian Society of Cardiovascular Surgery, Nova Lima, BH, Brazil, April 5 and 6, 2019
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Dallan, Luís Alberto O.
; Paez, Rodrigo Pereira
; Hossne Junior, Nelson Américo
; Santo, José Amalth do Espírito
; Berwanger, Otavio
; Santos, Renato Hideo Nakagawa
; Kalil, Renato Abdala Karam
; Jatene, Fabio B.
; Cavalcanti, Alexandre Biasi
; Zilli, Alexandre Cabral
; Bettiati Jr, Luiz Carlos
; Figueira, Fernando Augusto Marinho dos Santos
; D’Azevedo, Stephanie Steremberg Pires
; Soares, Marcelo José Ferreira
; Fernandes, Marcio Pimentel
; Ardito, Roberto Vito
; Bogdan, Renata Andrea Barberio
; Campagnucci, Valquíria Pelisser
; Nakasako, Diana
; Rodrigues, Clarissa Garcia
; Rodrigues Junior, Anilton Bezerra
; Cascudo, Marcelo Matos
; Atik, Fernando Antibas
; Lima, Elson Borges
; Nina, Vinicius José da Silva
; Heluy, Renato Albuquerque
; Azeredo, Lisandro Gonçalves
; Henrique Junior, Odilon Silva
; Mendonça, José Teles de
; Silva, Katharina Kelly de Oliveira Gama
; Pandolfo, Marcelo
; Lima Júnior, José Dantas de
; Faria, Renato Max
; Santos, Jonas Gonçalves dos
; Coelho, Guilherme Henrique Biachi
; Pereira, Sergio Nunes
; Senger, Roberta
; Buffolo, Enio
; Caputi, Guido Marco
; Oliveira, Juliana Aparecida Borges de
; Gomes, Walter J.
.
Brazilian Journal of Cardiovascular Surgery
- Journal Metrics
https://doi.org/10.21470/1678-9741-2019-0606
335 downloads
12.
Coronary Artery Bypass Surgery in Brazil: Analysis of the National Reality Through the BYPASS Registry
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Paez, Rodrigo Pereira
; Hossne Junior, Nelson Américo
; Santo, José Amalth do Espírito
; Berwanger, Otavio
; Santos, Renato Hideo Nakagawa
; Kalil, Renato Abdala Karam
; Jatene, Fabio B.
; Cavalcanti, Alexandre Biasi
; Zilli, Alexandre Cabral
; Bettiati Jr, Luiz Carlos
; Figueira, Fernando Augusto Marinho dos Santos
; D'Azevedo, Stephanie Steremberg Pires
; Soares, Marcelo José Ferreira
; Fernandes, Marcio Pimentel
; Ardito, Roberto Vito
; Bogdan, Renata Andrea Barberio
; Campagnucci, Valquíria Pelisser
; Nakasako, Diana
; Rodrigues, Clarissa Garcia
; Rodrigues Junior, Anilton Bezerra
; Cascudo, Marcelo Matos
; Atik, Fernando Antibas
; Lima, Elson Borges
; Nina, Vinicius José da Silva
; Heluy, Renato Albuquerque
; Azeredo, Lisandro Gonçalves
; Henrique Junior, Odilon Silva
; Mendonça, José Teles de
; Silva, Katharina Kelly de Oliveira Gama
; Pandolfo, Marcelo
; Lima Júnior, José Dantas de
; Faria, Renato Max
; Santos, Jonas Gonçalves dos
; Coelho, Guilherme Henrique Biachi
; Pereira, Sergio Nunes
; Senger, Roberta
; Buffolo, Enio
; Caputi, Guido Marco
; Oliveira, Juliana Aparecida Borges de
; Gomes, Walter J.
.
Brazilian Journal of Cardiovascular Surgery
- Journal Metrics
Abstract Introduction: Coronary artery bypass grafting (CABG) is the most frequently performed heart surgery in Brazil. Recent international guidelines recommend that national societies establish a database on the practice and results of CABG. In anticipation of the recommendation, the BYPASS Registry was introduced in 2015. Objective: To analyze the profile, risk factors and outcomes of patients undergoing CABG in Brazil, as well as to examine the predominant surgical strategy, based on the data included in the BYPASS Registry. Methods: A cross-sectional study of 2292 patients undergoing CABG surgery and cataloged in the BYPASS Registry up to November 2018. Demographic data, clinical presentation, operative variables, and postoperative hospital outcomes were analyzed. Results: Patients referred to CABG in Brazil are predominantly male (71%), with prior myocardial infarction in 41.1% of cases, diabetes in 42.5%, and ejection fraction lower than 40% in 9.7%. The Heart Team indicated surgery in 32.9% of the cases. Most of the patients underwent cardiopulmonary bypass (87%), and cardioplegia was the strategy of myocardial protection chosen in 95.2% of the cases. The left internal thoracic artery was used as a graft in 91% of the cases; the right internal thoracic artery, in 5.6%; and the radial artery in 1.1%. The saphenous vein graft was used in 84.1% of the patients, being the only graft employed in 7.7% of the patients. The median number of coronary vessels treated was 3. Operative mortality was 2.8%, and the incidence of cerebrovascular accident was 1.2%. Conclusion: CABG data in Brazil provided by the BYPASS Registry analysis are representative of our national reality and practice. This database constitutes an important reference for indications and comparisons of therapeutic procedures, as well as to propose subsequent models to improve patient safety and the quality of surgical practice in the country.
https://doi.org/10.21470/1678-9741-2018-0313
1270 downloads
13.
The Brazilian Registry of Adult Patient Undergoing Cardiovascular Surgery, the BYPASS Project: Results of the First 1,722 Patients
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Gomes, Walter J.
; Moreira, Rita Simone
; Zilli, Alexandre Cabral
; Bettiati Jr, Luiz Carlos
; Figueira, Fernando Augusto Marinho dos Santos
; D' Azevedo, Stephanie Steremberg Pires
; Soares, Marcelo José Ferreira
; Fernandes, Marcio Pimentel
; Ardito, Roberto Vito
; Bogdan, Renata Andrea Barberio
; Campagnucci, Valquíria Pelisser
; Nakasako, Diana
; Kalil, Renato Abdala Karam
; Rodrigues, Clarissa Garcia
; Rodrigues Junior, Anilton Bezerra
; Cascudo, Marcelo Matos
; Atik, Fernando Antibas
; Lima, Elson Borges
; Nina, Vinicius José da Silva
; Heluy, Renato Albuquerque
; Azeredo, Lisandro Gonçalves
; Henrique Junior, Odilon Silva
; Mendonça, José Teles de
; Silva, Katharina Kelly de Oliveira Gama
; Pandolfo, Marcelo
; Lima Júnior, José Dantas de
; Faria, Renato Max
; Santos, Jonas Gonçalves dos
; Paez, Rodrigo Pereira
; Coelho, Guilherme Henrique Biachi
; Pereira, Sergio Nunes
; Senger, Roberta
; Buffolo, Enio
; Caputi, Guido Marco
; Santo, José Amalth do Espírito
; Oliveira, Juliana Aparecida Borges de
; Berwanger, Otavio
; Cavalcanti, Alexandre Biasi
; Jatene, Fabio B.
.
Abstract Objective: To report the early results of the BYPASS project - the Brazilian registrY of adult Patient undergoing cArdiovaScular Surgery - a national, observational, prospective, and longitudinal follow-up registry, aiming to chart a profile of patients undergoing cardiovascular surgery in Brazil, assessing the data harvested from the initial 1,722 patients. Methods: Data collection involved institutions throughout the whole country, comprising 17 centers in 4 regions: Southeast (8), Northeast (5), South (3), and Center-West (1). The study population consists of patients over 18 years of age, and the types of operations recorded were: coronary artery bypass graft (CABG), mitral valve, aortic valve (either conventional or transcatheter), surgical correction of atrial fibrillation, cardiac transplantation, mechanical circulatory support and congenital heart diseases in adults. Results: 83.1% of patients came from the public health system (SUS), 9.6% from the supplemental (private insurance) healthcare systems; and 7.3% from private (out-of -pocket) clinic. Male patients comprised 66%, 30% were diabetics, 46% had dyslipidemia, 28% previously sustained a myocardial infarction, and 9.4% underwent prior cardiovascular surgery. Patients underwent coronary artery bypass surgery were 54.1% and 31.5% to valve surgery, either isolated or combined. The overall postoperative mortality up to the 7th postoperative day was 4%; for CABG was 2.6%, and for valve operations, 4.4%. Conclusion: This first report outlines the consecution of the Brazilian surgical cardiac database, intended to serve primarily as a tool for providing information for clinical improvement and patient safety and constitute a basis for production of research protocols.
https://doi.org/10.21470/1678-9741-2017-0053
1883 downloads
14.
II Diretriz de Ressonância Magnética e Tomografia Computadorizada Cardiovascular da Sociedade Brasileira de Cardiologia e do Colégio Brasileiro de Radiologia
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Sara, Leonardo
; Szarf, Gilberto
; Tachibana, Adriano
; Shiozaki, Afonso Akio
; Villa, Alexandre Volney
; Oliveira, Amarino Carvalho de
; Albuquerque, Andrei Skromov de
; Rochitte, Carlos Eduardo
; Nomura, César Higa
; Azevedo, Clerio Francisco
; Jasinowodolinski, Dany
; Tassi, Eduardo Marinho
; Medeiros, Fabio de Morais
; Kay, Fernando Uliana
; Junqueira, Flávia Pegado
; Azevedo, Guilherme S. A.
; Monte, Guilherme Urpia
; Pinto, Ibraim Masciarelli Francisco
; Gottlieb, Ilan
; Andrade, Joalbo
; Lima, João A. C.
; Parga Filho, José Rodrigues
; Kelendjian, Juliana
; Fernandes, Juliano Lara
; Iquizli, Leonardo
; Correia, Luis C. L.
; Quaglia, Luiz Augusto
; Gonçalves, Luiz Flavio Galvão
; Ávila, Luiz Francisco
; Zapparoli, Marcello
; Hadlich, Marcelo
; Nacif, Marcelo Souto
; Barbosa, Márcia de Melo
; Minami, Márcio Hiroshi
; Bittencourt, Marcio Sommer
; Siqueira, Maria Helena Albernaz
; Silva, Marly Conceição
; Lopes, Marly Maria Uellendahl
; Marques, Mateus Diniz
; Vieira, Mônica La Rocca
; Coellho Filho, Otávio Rizzi
; Schvartzman, Paulo R.
; Santos, Raul D.
; Cury, Ricardo C.
; Loureiro, Ricardo
; Cury, Roberto Caldeira
; Sasdelli Neto, Roberto
; Macedo, Robson
; Cerci, Rodrigo Julio
; Faria Filho, Rui Alberto de
; Cardoso, Sávio
; Naves, Thiago
; Magalhães, Tiago Augusto
; Senra, Tiago
; Burgos, Ursula Maria Moreira Costa
; Moreira, Valéria de Melo
; Ishikawa, Walther Yoshiharu
.
15.
Composição florística e estrutura do estrato inferior da floresta de várzea na área de proteção ambiental Ilha do Combu, município de Belém, estado do Pará
Facebook Twitter
Facebook Twitter
- Other social networks
- Google+
- StambleUpon
- CiteULike
- Mendeley
- Other networks
- Metrics
Maués, Bernardo Antônio Rodrigues
; Jardim, Mário Augusto Gonçalves
; Batista, Fábio de Jesus
; Medeiros, Tonny David Santiago
; Quaresma, Adriano da Costa
.
O estrato inferior é formado pela regeneração das espécies arbóreas, arbustivas, herbáceas, epífitas e lianas formando um nicho ecológico de vital importância para o estabelecimento e desenvolvimento da floresta. Com o objetivo de analisar a composição florística e a estrutura do estrato inferior da floresta de várzea na APA Ilha do Combu, Belém, Pará, foram alocadas 50 parcelas de 50 x 4 m e divididas em 25 subparcelas de 2 x 2 m. Foram identificadas e quantificadas todas as espécies com Diâmetro à Altura do Peito (DAP) d" 10 cm. Calcularam-se a diversidade, densidade e frequência relativas, categoria de tamanho relativa e regeneração natural relativa. Foram amostrados 22.221 indivíduos, 67 famílias, 153 gêneros e 223 espécies, e o índice de Shannon (H') foi de 3,72 nat/ind e a equabilidade (J'), de 0,69. Fabaceae, Malvaceae e Arecaceae destacaram-se em riqueza de espécies e Euterpe oleracea e Virola surinamensis em densidade relativa, categoria de tamanho relativa e regeneração natural relativa. O hábito arbóreo apresentou o maior número de espécies e indivíduos nas classes de tamanhos 1 e 2. Os mecanismos de adaptação e a produção de frutos estão relacionados com a diversidade da área, onde as espécies com estratégias mais eficientes são dominantes e mais representativas quantitativamente na comunidade.
The lower stratum is formed by the regeneration of arboreous, arbustive, herbaceous, epiphyte, and liana species, forming an ecological niche of vital importance to the establishment and development of the forest. To analyze floristic composition and structure of the lower stratum of the floodplain forest, it was allocated fifty 50 × 4-m plots, divided in 25 2 × 2-m subplots. All species with diameter at breast height (DBH) < 10cm were identified and quantified. Relative diversity, density and frequency, relative category of size, and relative natural regeneration were calculated. It was sampled 22,221 individuals, 67 families, 153 genera and 223 species, and the Shannon index (H') was 3.72 nat/ind and Equability (J') was 0.69. Fabaceae, Malvaceae and Arecaceae stood out for species richness, and Euterpe oleracea and Virola surinamensis for relative density, relative category of size, and relative natural regeneration. The arboreous habit presented the greatest number of species and individuals in the size classes 1 and 2. The adaptation mechanisms and fruit production are related to the diversity of the area, where the species with the most efficient strategies are dominant and more quantitatively representatives in the community.
3901 downloads
Showing
itens per page
Page
of 2
Next
Statistics of
Send result
Sem resultados
No documents were found for your search
Glossary and search help
You can enrich your search in a very simple way. Use the search indexes combined with the connectors (AND or OR) and specify more your search.
For example, if you want to search for articles about
cases of dengue in Brasil in 2015, use:ti:dengue and publication_year:2015 and aff_country:Brasil
See below the complete list of search indexes that can be used:
Index code | Element |
---|---|
ti | article title |
au | author |
kw | article keywords |
subject | subject (title words, abstract and keywords) |
ab | abstract |
ta | journal short title (e.g. Cad. Saúde Pública) |
journal_title | journal full title (e.g. Cadernos de Saúde Pública) |
la | publication language code (e.g. pt - Portuguese, es - Spanish) |
type | document type |
pid | publication identifier |
publication_year | publication year of publication |
sponsor | sponsor |
aff_country | country code of the author's affiliation |
aff_institution | author affiliation institution |
volume | article volume |
issue | article issue |
elocation | elocation |
doi | DOI number |
issn | journal ISSN |
in | SciELO colection code (e.g. scl - Brasil, col - Colômbia) |
use_license | article usage license code |